Study to see effect of giving Vitamin B12 on blood and nerve in preterm and low birth weight newborn

A comparative study to assess the Neurological and Hematological outcome following vitamin B12 supplementation in low birth weight preterm neonates in NICU of a tertiary care hospital - NEOB12

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2019/12/022299

Enrollment

200

Registered

2019-12-11

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: D519- Vitamin B12 deficiency anemia, unspecified

Interventions

Intervention1: Single dose Injection Vitamin B12 1000mcg: Group A receiving single dose Injection Vitamin B12 1000mcg Control Intervention1: Not receiving Single dose Injection Vitamin B12 1000mcg: Gr

Eligibility

Inclusion criteria

Inclusion criteria: Preterm Babies ( <37 weeks of gestation) or Birth weight <2 kg

Exclusion criteria

Exclusion criteria: Those who are on long term ( >72hr) ventilation Patient with major congenital anomaly

Design outcomes

Primary

Measure	Time frame
TO assess the improvement in hematological outcome after Vit B12 supplementationTimepoint: On admission and weekly till discharge and at discharge and at 6 and/ or 14 weeks	—

Secondary

Measure	Time frame
To assess the improvement in neurological outcome after Vit B12 supplementationTimepoint: At discharge and at 6 and/ or 14 weeks	—

Countries

India

Contacts

Public ContactJayendra R Gohil

Sir T hospital Bhavnagar

jayukids@yahoo.com9426348908

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026